Purification of the inducible nitric oxide synthase.
Garvey
E P
EP
Glaxo Wellcome, Research Triangle Park, NC, USA.
D000230:Adenocarcinoma; D000818:Animals; D002460:Cell Line; D002846:Chromatography, Affinity / Q000379:methods; D002850:Chromatography, Gel / Q000379:methods; D003110:Colonic Neoplasms; D006801:Humans; D007202:Indicators and Reagents; D007700:Kinetics; D051379:Mice; D019001:Nitric Oxide Synthase / Q000737:chemistry / Q000302:isolation & purification* / Q000378:metabolism; D052247:Nitric Oxide Synthase Type II; D014407:Tumor Cells, Cultured
D007202:Indicators and Reagents; C496319:NOS2 protein, human; D019001:Nitric Oxide Synthase; D052247:Nitric Oxide Synthase Type II; C496317:Nos2 protein, mouse